U.S. Capital Wealth Advisors LLC Boosts Stake in Cardinal Health, Inc. $CAH

Key Points

• U.S. Capital Wealth Advisors LLC significantly increased its stake in Cardinal Health, Inc. by 457.5% during the 2nd quarter, now owning 33,219 shares valued at approximately $5.58 million.
• Cardinal Health's stock is currently priced at $147.61, with a market cap of $35.07 billion, and it has a 52-week high of $168.44.
• The company announced a quarterly dividend of $0.5107 per share, equating to an annualized dividend of $2.04 and a dividend yield of 1.4%.

U.S. Capital Wealth Advisors LLC boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 457.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 33,219 shares of the company's stock after purchasing an additional 27,260 shares during the period. U.S. Capital Wealth Advisors LLC's holdings in Cardinal Health were worth $5,581,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CAH. Waverly Advisors LLC increased its holdings in Cardinal Health by 8.5% in the 4th quarter. Waverly Advisors LLC now owns 3,098 shares of the company's stock worth $366,000 after acquiring an additional 243 shares in the last quarter. Vise Technologies Inc. purchased a new stake in shares of Cardinal Health in the fourth quarter worth $255,000. Sunbelt Securities Inc. increased its stake in shares of Cardinal Health by 29.3% in the fourth quarter. Sunbelt Securities Inc. now owns 1,775 shares of the company's stock worth $209,000 after purchasing an additional 402 shares in the last quarter. GF Fund Management CO. LTD. bought a new stake in shares of Cardinal Health during the 4th quarter valued at $704,000. Finally, Toronto Dominion Bank lifted its stake in shares of Cardinal Health by 10.2% during the 4th quarter. Toronto Dominion Bank now owns 132,697 shares of the company's stock valued at $15,694,000 after buying an additional 12,236 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Down 1.3%

CAH opened at $147.61 on Tuesday. The business has a fifty day moving average of $152.78 and a 200 day moving average of $148.84. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44. The stock has a market cap of $35.07 billion, a P/E ratio of 22.89, a PEG ratio of 1.27 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the company earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. Cardinal Health's dividend payout ratio (DPR) is 31.63%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a report on Tuesday, August 12th. Leerink Partners decreased their target price on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 12th. Argus set a $189.00 price target on Cardinal Health in a report on Friday, August 22nd. Morgan Stanley restated an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $165.93.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company's stock, valued at $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.